5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Iovance Biotherapeutics Inc. (IOVA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.15 | 250,000 | Director | 320,150 | 2024-02-20 | Filing | |
| $9.15 | 32,000 | Director | 54,000 | 2024-02-20 | Filing | |
| $9.15 | 5,000,000 | Director | 28,067,333 | 2024-02-20 | Filing | |
| $5.56 | 10,000 | Director | 248,633 | 2023-09-18 | Filing | |
| $5.30 | 5,000,000 | Director | 23,067,333 | 2023-09-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.71 | 20,500 | Director | 100,000 | 2016-08-25 | Filing | |
| $9.10 | 33,500 | Director | 120,500 | 2016-08-24 | Filing | |
| $9.11 | 54,000 | Director | 100,000 | 2016-08-22 | Filing | |
| $7.13 | 16,500 | Director | 154,000 | 2015-09-08 | Filing | |
| $6.84 | 16,000 | Director | 170,500 | 2015-09-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,812,820 | $185,468,227 | 0% | |
| 2. | 19,071,756 | $155,053,376 | 0% | |
| 3. | 16,424,388 | $133,530,274 | 0% | |
| 4. | 5,263,309 | $42,790,702 | 0.04% | |
| 5. | 5,037,098 | $40,956,054 | 0% |
News See All
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Paul Tudor Jones and...
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript
Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.45 EPS, expectations were $-0.44. Iovance Biotherapeutics, Inc.
5 Stocks With Heavy Insider Buying In 2024
Wayne Rothbaum is a board member at California-based Iovance Biotherapeutics, Inc (NASDAQ:IOVA).
5 Best Short Squeeze Stocks To Buy Now
In this piece, we will take a look at the five best short squeeze stocks to buy now.
5 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the five most promising cancer stocks according to analysts.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2023 Financial Results and Corporate Update Conference Call.
Should You Exit Iovance Biotherapeutics (IOVA) Following the Recent Uncertainty?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: Cathie Wood, Steve Cohen, Ress Capital, Brevan Howard Asset Management, ExodusPoint Capital Management, CNX Resources Corp (CNX), Iovance Biotherapeutics, Inc. (IOVA), and More
Investors will flock to funds focusing on buzzy themes when the Federal Reserve cuts interest rates, according to Cathie Wood, who is doubling down on innovative investment strategies with a new acquisition...
Billionaire Hedge Funds
